The plasma IGFBP-2 levels of COVID-19 patients were higher in contrast to the healthy controls (p < 0.001; Figure 3b) (AUROC 0.879; p < 0.001; 95% CI 0.773–0.985). The gene discussed is IGFBP2; the disease is COVID-19.